New Mexico Clinical Research & Osteoporosis Center

Recent papers from New Mexico Clinical Research & Osteoporosis Center

1. Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis FoundationOsteoporosis International · 2026
2. Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific regionOsteoporosis International · 2026
3. Making VFA Part of Standard Clinical DXA Assessment for Osteoporosis CareMayo Clinic Proceedings · 2025
4. Proceedings of the 2025 Santa Fe Bone Symposium: Current concepts in the care of patients with osteoporosis, parathyroid disorders, and rare bone diseasesJournal of Clinical Densitometry · 2025
5. Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosisJBMR Plus · 2025
6. Early Clinical Outcomes of a Nitrided Ti-6Al-4V Titanium Alloy Anatomic Total Knee Replacement SystemOsteology · 2025
7. X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism · 2025
8. Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatideJournal of Bone and Mineral Research · 2025
9. Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert ExperienceThe Journal of Clinical Endocrinology & Metabolism · 2025
10. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism · 2025
11. Bone turnover markers predict changes in bone mineral density in men treated with abaloparatide: results from the abaloparatide for the treatment of men with osteoporosis (ATOM) studyJournal of Bone and Mineral Research · 2025
12. Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone DiseasesJournal of Clinical Densitometry · 2024
13. Systematic Review: Efficacy of Medical Therapy on Outcomes Important to Adult Patients With X-Linked HypophosphatemiaThe Journal of Clinical Endocrinology & Metabolism · 2024
14. Bone Health ECHO Case Report: Significant Elevation in Bone Turnover Markers and Progression of Vertebral Fractures After Denosumab Discontinuation Followed by a PTH-AnalogJournal of Clinical Densitometry · 2024
15. 6820 Assessing The Efficacy And Safety Of Setrusumab For Osteogenesis Imperfecta: Updated Phase 2 Data From The Phase 2/3 Orbit StudyJournal of the Endocrine Society · 2024
16. 6451 Bone Health ECHO: Expanding Global Capacity To Deliver Best Practice Skeletal HealthcareJournal of the Endocrine Society · 2024
17. 6733 Bone Turnover Markers Predict Bone Mineral Density Increases With Abaloparatide In Men Similarly To Women: Results From ATOMJournal of the Endocrine Society · 2024
18. 12589 Two Systematic Reviews Of Treatment Efficacy On Patient Important Outcomes In Adult X-linked HypophosphatemiaJournal of the Endocrine Society · 2024
19. Updated practice guideline for dual-energy X-ray absorptiometry (DXA)European Journal of Nuclear Medicine and Molecular Imaging · 2024
20. Goal-Directed Osteoporosis Treatment: ASBMR/BHOF Task Force Position Statement 2024Journal of Bone and Mineral Research · 2024